Get your Pfizer COVID-19 vaccine. Walk-ins welcome! Mon., Wed., Fri.: 8 a.m. - 5 p.m. and Tues., Thurs.: 8 a.m. - 7 p.m. >

A Phase II Trial of Ribociclib (LEE011) Plus Letrozole in Women With Recurrent Low-Grade Serous Carcinoma of the Ovary, Fallopian Tube or Peritoneum (GOG-3026)

Investigator: Aparna Kamat, MD

Study Coordinator: Jaya Kamath

Status: Enrolling

ClinicalTrials.gov Number: NCT03673124

Phone: 713.441.6616

Protocol Number: Pro00021786

Description

The study evaluates the response to treatment with Ribociclib and Letrozole in patients with recurrent low grade serous cancer of the ovary, fallopian tube or peritoneum.
More to Explore
Search Clinical Trials
Join a Clinical Trial
Clinical Research Support Services for Investigators
Weill Cornell Medical College Clinical Trials